# BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

> **NCT00756548** · PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 386 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** BLI850
- **DRUG:** polyethylene glycol 3350 based bowel preparation

## Key facts

- **NCT ID:** NCT00756548
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 386 (ACTUAL)
- **Last updated:** 2013-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756548, "BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00756548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*